Golob Laura, Mercado-Munoz Yesica, Liu Wenxi, Singh Anvita, Hodges James S, Siegel Lianne, Morero Helena, Gao Zan, Tipp Angela, Simon Stacey L, Sarafoglou Kyriakie
Division of Pediatric Endocrinology, University of Minnesota Medical School, Minneapolis, MN 55454, USA.
Department of Physical Education, Shanghai Jiao Tong University, Shanghai 200240, China.
J Clin Endocrinol Metab. 2025 Jul 15;110(8):e2647-e2653. doi: 10.1210/clinem/dgae836.
Literature on sleep health in children with congenital adrenal hyperplasia (CAH) is sparse despite the important role the hypothalamic-pituitary-adrenal axis plays in sleep onset, duration, and awakenings after sleep onset.
To evaluate sleep health in children and adolescents with CAH as measured by wrist actigraphy and validated sleep questionnaires.
Cross-sectional study at our multidisciplinary CAH clinic. Participants aged 3 to 18 years with classic CAH wore an ActiGraph GT3X+ accelerometer for 1 week. Children and parents completed sleep questionnaires, and the results were compared to published samples from the community and children with sleep disorders (clinical). Actigraphy sleep health measures were compared to consensus sleep duration recommendations and normative data in healthy children.
Forty-four participants (23 male) with CAH completed the study. Actigraphy found sleep duration in children with CAH was less than recommended guidelines with significantly worse sleep efficiency and increased wake after sleep onset (P < .05) compared to healthy children. After sleep onset, the average number of awakenings increased from 1.67 per hour during the first 2 hours after the evening hydrocortisone dose to 3.12 per hour 4 to 7 hours after the dose, corresponding with washout of the evening hydrocortisone dose. Parents of 3- to 10-year-olds reported significantly worse sleep onset delay and decreased sleep duration than both the community and clinical samples, and significantly more night awakenings than the community sample.
Our findings suggest that sleep health is impaired in children with CAH and is an important consideration for both clinical practice and future research.
尽管下丘脑 - 垂体 - 肾上腺轴在睡眠起始、持续时间及睡眠起始后的觉醒中起着重要作用,但关于先天性肾上腺皮质增生症(CAH)患儿睡眠健康的文献却很稀少。
通过手腕活动记录仪和经过验证的睡眠问卷来评估CAH患儿及青少年的睡眠健康状况。
在我们的多学科CAH诊所进行横断面研究。年龄在3至18岁的经典型CAH参与者佩戴ActiGraph GT3X +加速度计1周。儿童及其父母完成睡眠问卷,并将结果与已发表的社区样本及患有睡眠障碍的儿童(临床样本)进行比较。将活动记录仪测量的睡眠健康指标与健康儿童的共识睡眠时长建议及规范数据进行比较。
44名(23名男性)患有CAH的参与者完成了研究。活动记录仪发现,与健康儿童相比,CAH患儿的睡眠时间低于推荐指南,睡眠效率明显更差,睡眠起始后觉醒增加(P <.05)。睡眠起始后,觉醒的平均次数从晚上服用氢化可的松剂量后的前2小时内每小时1.67次增加到服药后4至7小时的每小时3.12次,这与晚上氢化可的松剂量的消退相对应。3至10岁儿童的父母报告称,与社区样本和临床样本相比,孩子的睡眠起始延迟明显更差,睡眠时间减少,且夜间觉醒次数明显多于社区样本。
我们的研究结果表明,CAH患儿的睡眠健康受损,这在临床实践和未来研究中都是一个重要的考虑因素。